Genetics and Your Family's Heart Health
At a Glance
Left ventricular noncompaction (LVNC) can share inherited gene changes with dilated or hypertrophic cardiomyopathy, so parents, siblings, and children may need genetic counseling, heart tests, and repeat screening even after a normal first check.
Understanding Left Ventricular Noncompaction (LVNC) often requires looking beyond one person’s heart and examining the family’s “genetic map.” Because LVNC is frequently associated with inherited genetic mutations, your diagnosis may provide important clues for the health of your parents, siblings, and children [1][2].
The Genetic Overlap
One of the most surprising findings in modern cardiology is that LVNC does not have its “own” unique set of genes. Instead, there is a massive overlap with other heart muscle diseases [3]. The genes most commonly linked to LVNC—such as MYH7, TTN (Titin), and MYBPC3—are the same genes that cause Dilated Cardiomyopathy (DCM, where the heart becomes large and weak) and Hypertrophic Cardiomyopathy (HCM, where the heart muscle becomes too thick) [3][4].
Because of this “genetic shared space,” two people in the same family with the same genetic mutation might have hearts that look completely different: one might have a “spongy” heart (LVNC), while the other has a “weak” heart (DCM) without any extra muscle bundles [5].
When Is Genetic Testing Most Useful?
Genetic testing is a powerful tool, but its “yield” (the chance of finding a clear pathogenic variant) varies widely depending on your specific heart function and the cohort being studied [6]:
- LVNC with Dysfunction: If your heart is weak (low ejection fraction) or enlarged, genetic testing is more likely to find a “pathogenic” (disease-causing) variant [6][7].
- Isolated LVNC: If your heart function is perfectly normal and you have no symptoms, the yield of genetic testing is much lower. In one specific study of children with isolated LVNC and no family history, the yield was reported as 0% [6]. However, this does not mean a negative test proves the condition is harmless. A normal EF or a negative panel does not exclude a genetic cause entirely due to untested genes or test limitations.
- Variants of Uncertain Significance (VUS): Sometimes a test finds a genetic change, but scientists aren’t sure if it causes disease or is just a normal human variation. A VUS should not be used alone for predictive testing or making major treatment decisions [8].
Family “Cascade” Screening
If you are diagnosed with LVNC, doctors often recommend a process called cascade screening for your first-degree relatives (parents, siblings, and children) [9][10].
- Clinical Screening: When indicated, relatives should have a physical exam, an ECG (heart rhythm strip), and an echocardiogram (ultrasound) [11]. If a specific familial mutation is known, targeted genetic testing can also be used.
- Looking for “Hidden” Disease: The goal is to look for any signs of cardiomyopathy, not just “spongy” hearts [2].
- Age-Dependent Penetrance: In some family cohorts, a significant percentage of relatives carrying a known mutation (up to 37% in one study) showed a completely normal-looking heart on their first scan [2]. This means a normal first scan does not guarantee lifelong safety. Relatives may need repeat screenings at age-specific intervals to ensure disease doesn’t develop later in life [10].
LVNC in Children: A Unique Journey
The presentation of LVNC in children can differ significantly from adults.
- Infancy and the “Dilated” Phenotype: Some babies are born with a severe form of LVNC where the heart is both “spongy” and severely enlarged (dilated) [12]. This often causes heart failure symptoms very early in life. Children with this phenotype carry a higher risk of needing a transplant compared to those with isolated LVNC [13][14].
- Potential for Recovery: Children’s hearts can sometimes remodel beautifully with treatment. While outcomes vary, in one specific cohort of children and young adults with weak hearts and LVNC, 88% showed improvement in their pumping function after starting standard heart failure medications [15]. This highlights that while disease can be severe, recovery is possible.
- Other Conditions: In children, LVNC is more likely to be associated with congenital heart defects, neuromuscular diseases, or metabolic conditions [6][16]. A pediatric cardiologist will assess overall development to ensure LVNC isn’t part of a larger syndromic puzzle [16].
Genetic counseling is highly recommended to help families navigate the emotional, reproductive, and practical implications of testing, ensuring you understand exactly what the results mean for you and your relatives [1]. Ultimately, your clinical function (how you feel and how your heart pumps) remains the most important guide for your daily care [17].
Common questions in this guide
Can left ventricular noncompaction run in families?
Who should be screened when someone has LVNC?
Does a negative LVNC genetic test rule out inherited disease?
What does a VUS mean on an LVNC genetic test?
How often should relatives be rechecked after a normal heart scan?
Can a child with LVNC improve with treatment?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Left ventricular noncompaction.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Is my genetic profile more consistent with the genes linked to dilated cardiomyopathy (DCM) or hypertrophic cardiomyopathy (HCM)?
- 2.If my genetic test is 'negative,' what are the chances that my 'spongy' heart is just a normal variation rather than a genetic disease?
- 3.How often should my children or siblings have repeat echocardiograms, even if their first screening was normal?
- 4.For a child diagnosed in infancy, what are the specific measurements of their heart enlargement and how do those affect their long-term recovery chances?
- 5.Does our family have any signs of neuromuscular issues or syndromic features that might change which genetic panel we use?
References
References (17)
- 1
Loss of Function Mutations in NNT Are Associated With Left Ventricular Noncompaction.
Bainbridge MN, Davis EE, Choi WY, et al.
Circulation. Cardiovascular genetics 2015; (8(4)):544-52 doi:10.1161/CIRCGENETICS.115.001026.
PMID: 26025024 - 2
Cardiac Phenotypes, Genetics, and Risks in Familial Noncompaction Cardiomyopathy.
van Waning JI, Caliskan K, Michels M, et al.
Journal of the American College of Cardiology 2019; (73(13)):1601-1611 doi:10.1016/j.jacc.2018.12.085.
PMID: 30947911 - 3
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies.
Mazzarotto F, Hawley MH, Beltrami M, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2021; (23(5)):856-864 doi:10.1038/s41436-020-01049-x.
PMID: 33500567 - 4
MYH7 variants cause complex congenital heart disease.
Ritter A, Leonard J, Gray C, et al.
American journal of medical genetics. Part A 2022; (188(9)):2772-2776 doi:10.1002/ajmg.a.62766.
PMID: 35491958 - 5
Different Phenotypes of Sarcomeric MyBPC3-Cardiomyopathy in the Same Family: Hypertrophic, Left Ventricular Noncompaction and Restrictive Phenotypes (in Association with Sarcoidosis).
Blagova O, Pavlenko E, Sedov V, et al.
Genes 2022; (13(8)) doi:10.3390/genes13081344.
PMID: 36011256 - 6
Genetic Testing in Pediatric Left Ventricular Noncompaction.
Miller EM, Hinton RB, Czosek R, et al.
Circulation. Cardiovascular genetics 2017; (10(6)) doi:10.1161/CIRCGENETICS.117.001735.
PMID: 29212898 - 7
Genetic landscape in Russian patients with familial left ventricular noncompaction.
Meshkov AN, Myasnikov RP, Kiseleva AV, et al.
Frontiers in cardiovascular medicine 2023; (10()):1205787 doi:10.3389/fcvm.2023.1205787.
PMID: 37342443 - 8
Cardiomyopathies and Genetic Testing in Heart Failure: Role in Defining Phenotype-Targeted Approaches and Management.
Yogasundaram H, Alhumaid W, Dzwiniel T, et al.
The Canadian journal of cardiology 2021; (37(4)):547-559 doi:10.1016/j.cjca.2021.01.016.
PMID: 33493662 - 9
Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis.
Negri F, De Luca A, Fabris E, et al.
Heart failure reviews 2019; (24(3)):315-323 doi:10.1007/s10741-018-9763-3.
PMID: 30612215 - 10
Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy.
Schultze-Berndt A, Kühnisch J, Herbst C, et al.
Frontiers in pediatrics 2021; (9()):722926 doi:10.3389/fped.2021.722926.
PMID: 34540771 - 11
Inherited Hypertrabeculation? Genetic and Clinical Insights in Blood Relatives of Genetically Affected Left Ventricular Excessive Trabeculation Patients.
Mester B, Lipták Z, Farkas-Sütő KA, et al.
Life (Basel, Switzerland) 2025; (15(2)) doi:10.3390/life15020150.
PMID: 40003559 - 12
Long-Term Outcomes of Childhood Left Ventricular Noncompaction Cardiomyopathy: Results From a National Population-Based Study.
Shi WY, Moreno-Betancur M, Nugent AW, et al.
Circulation 2018; (138(4)):367-376 doi:10.1161/CIRCULATIONAHA.117.032262.
PMID: 29514799 - 13
Left Ventricular Noncompaction Cardiomyopathy: Left Ventricular Dilation and Dysfunction at Baseline Portend the Risk of Death or Heart Transplantation.
Cardoso B, Jeewa A, Minn S, et al.
The Canadian journal of cardiology 2022; (38(6)):754-762 doi:10.1016/j.cjca.2022.01.030.
PMID: 35122937 - 14
Cardiomyopathy Phenotypes and Outcomes for Children With Left Ventricular Myocardial Noncompaction: Results From the Pediatric Cardiomyopathy Registry.
Jefferies JL, Wilkinson JD, Sleeper LA, et al.
Journal of cardiac failure 2015; (21(11)):877-84.
PMID: 26164213 - 15
Medical Therapy Leads to Favorable Remodeling in Left Ventricular Non-compaction Cardiomyopathy: Dilated Phenotype.
Parent JJ, Towbin JA, Jefferies JL
Pediatric cardiology 2016; (37(4)):674-7 doi:10.1007/s00246-015-1330-2.
PMID: 26724283 - 16
Left Ventricular Noncompaction in Children: The Role of Genetics, Morphology, and Function for Outcome.
Klaassen S, Kühnisch J, Schultze-Berndt A, Seidel F
Journal of cardiovascular development and disease 2022; (9(7)) doi:10.3390/jcdd9070206.
PMID: 35877568 - 17
Prognostic Significance of Left Ventricular Noncompaction: Systematic Review and Meta-Analysis of Observational Studies.
Aung N, Doimo S, Ricci F, et al.
Circulation. Cardiovascular imaging 2020; (13(1)):e009712 doi:10.1161/CIRCIMAGING.119.009712.
PMID: 31959004
This page provides general information about LVNC genetics and family screening and does not constitute medical advice. A cardiologist and genetic counselor can interpret your results and recommend appropriate testing or repeat screening for your relatives.